Elsewhere: [math people] [google] [google scholar]

- Bayesian semiparametric joint regression analysis of recurrent adverse events and survival in esophageal cancer patients. The Annals of Applied Statistics 2019. 13:221-247 .
- A Decision-Theoretic Comparison of Treatments to Resolve Air Leaks After Lung Surgery Based on Nonparametric Modeling. Bayesian Analysis 2017. 12:639-652 .
- Parametric dose standardization for optimizing two-agent combinations in a phase I–II trial with ordinal outcomes. Journal of the Royal Statistical Society: Series C (Applied Statistics) 2017. 66:201-224 .
- A simulation study of methods for selecting subgroup-specific doses in phase 1 trials. Pharmaceutical Statistics 2017. 16:143-156 .
- Clinical trial design as a decision problem. Applied Stochastic Models in Business and Industry 2017. 33:- .
- Bayesian group sequential clinical trial design using total toxicity burden and progression-free survival. Journal of the Royal Statistical Society: Series C (Applied Statistics) 2016. 65:273-297 .
- Utility-based designs for randomized comparative trials with categorical outcomes. Statistics in Medicine 2016. 35:4285-4305 .
- Bayesian nonparametric estimation of targeted agent effects on biomarker change to predict clinical outcome. Biometrics 2015. 71:188-197 .
- Optimization of multi-stage dynamic treatment regimes utilizing accumulated data. Statistics in Medicine 2015. 34:3424-3443 .
- Evaluating joint effects of induction–salvage treatment regimes on overall survival in acute leukaemia. Journal of the Royal Statistical Society: Series C (Applied Statistics) 2013. 62:67-83 .
- Using Joint Utilities of the Times to Response and Toxicity to Adaptively Optimize Schedule–Dose Regimes. Biometrics 2013. 69:673-682 .
- Bayesian Adaptive Dose-Finding Based on Efficacy and Toxicity. Journal of Statistical Research 2012. 46:187-202 .
- Estimating progression-free survival in paediatric brain tumour patients when some progression statuses are unknown. Journal of the Royal Statistical Society: Series C (Applied Statistics) 2012. 61:135-149 .
- Prior effective sample size in conditionally independent hierarchical models. Bayesian Analysis 2012. 7:591-614 .
- Defining and ranking effects of individual agents based on survival times of cancer patients treated with combination chemotherapies. Statistics in Medicine 2011. 30:1777-1794 .
- Optimizing the Concentration and Bolus of a Drug Delivered by Continuous Infusion. Biometrics 2011. 67:1638-1646 .
- Application of a Bayesian doubly optimal group sequential design for clinical trials. .
- Bayesian models and decision algorithms for complex early phase clinical trials. Statistical Science 2010. 25:227-244 .
- A Bayesian hierarchical mixture model for platelet-derived growth factor receptor phosphorylation to improve estimation of progression-free survival in prostate cancer. Journal of the Royal Statistical Society: Series C (Applied Statistics) 2010. 59:19-34 .
- Utility-based optimization of combination therapy using ordinal toxicity and efficacy in phase I/II trials. Biometrics 2010. 66:532-540 .
- Comment on ``A hybrid selection and testing procedure with curtailment for comparative clinical trials" (Pkg: p2-53). Sequential Analysis 2009. 28:41-43 .
- Bayesian adaptive model selection for optimizing group sequential clinical trials. Statistics in Medicine 2008. 27:5586-5604 .
- A review of phase 2–3 clinical trial designs. Lifetime Data Analysis 2008. 14:37-53 .
- Determining the Effective Sample Size of a Parametric Prior. Biometrics 2008. 64:595-602 .
- Some geometric methods for constructing decision criteria based on two-dimensional parameters. Journal of Statistical Planning and Inference 2008. 138:516-527 .
- Patient-Specific Dose Finding Based on Bivariate Outcomes and Covariates. Biometrics 2008. 64:1126-1136 .
- Accounting for patient heterogeneity in phase II clinical trials. Statistics in Medicine 2008. 27:2802-2815 .
- Bayesian and frequentist two-stage treatment strategies based on sequential failure times subject to interval censoring. Statistics in Medicine 2007. 26:4687-4702 .
- Comments on ``Continuous Bayesian adaptive randomization based on event times with covariates'' (2006V25 p55-70). Statistics in Medicine 2007. 26:3052-3054 .
- A geometric approach to comparing treatments for rapidly fatal diseases. Biometrics 2006. 62:193-201 .
- Determining a maximum-tolerated schedule of a cytotoxic agent. Biometrics 2005. 61:335-343 .
- Covariate-adjusted adaptive randomization in a sarcoma trial with multi-stage treatments. Statistics in Medicine 2005. 24:1947-1964 .
- Dose-finding based on multiple toxicities in a soft tissue sarcoma trial. Journal of the American Statistical Association 2004. 99:26-35 .
- Dose-Finding Based on Efficacy–Toxicity Trade-Offs. Biometrics 2004. 60:684-693 .
- Dose-finding based on efficacy?Toxicity trade-offs. Biometrics 2004. 60:684-693 .
- Hierarchical Bayesian approaches to phase II trials in diseases with multiple subtypes. Statistics in Medicine 2003. 22:763-780 .
- Dose-finding with two agents in phase I oncology trials. Biometrics 2003. 59:487-496 .
- Adaptive decision making in a lymphocyte infusion trial. Biometrics 2002. 58:560-568 .
- Selecting therapeutic strategies based on efficacy and death in multicourse clinical trials. Journal of the American Statistical Association 2002. 97:29-39 .
- Reply to comments on ``Multi-course treatment strategies for clinical trials of rapidly fatal diseases'' (Pkg: p33-89). .
- Multi-course treatment strategies for clinical trials of rapidly fatal diseases (Pkg: p33-89). .
- Seamlessly expanding a randomized phase II trial to phase III. Biometrics 2002. 58:823-831 .
- Ethical issues in oncology biostatistics. Statistical Methods in Medical Research 2002. 11:429-448 .
- Monitoring the rates of composite events with censored data in phase II clinical trials. Biometrics 2002. 58:89-97 .
- Optimal two-stage designs for clinical trials based on safety and efficacy. Statistics in Medicine 2001. 20:1023-1032 .
- Dose-finding based on feasibility and toxicity in T-cell infusion trials. Biometrics 2001. 57:914-921 .
- Decision-theoretic designs for pre-phase II screening trials in oncology. Biometrics 2001. 57:1089-1095 .
- Bayesian clinical trial design in a cancer center. CHANCE 2001. 14:23-28 .
- An explanation of generalized profile likelihoods. Statistics and Computing 2001. 11:293-298 .
- An explanation of generalized profile likelihoods. Statistics and Computing 2001. 11:293-298 .
- Evaluating multiple treatment courses in clinical trials. Statistics in Medicine 2000. 19:1011-1028 .
- Bayesian methods in early phase oncology trials. .
- Approximate Bayesian evaluation of multiple treatment effects. Biometrics 2000. 56:213-219 .
- Treatment comparisons based on two-dimensional safety and efficacy alternatives in oncology trials. Biometrics 1999. 55:746-753 .
- Decision theoretic designs for phase II clinical trials with multiple outcomes. Biometrics 1999. 55:971-977 .
- Treatment comparisons based on two-dimensional safety and efficacy alternatives in oncology trials. Biometrics 1999. 55:746-753 .
- Decision theoretic designs for phase II clinical trials with multiple outcomes. Biometrics 1999. 55:971-977 .
- Accrual strategies for phase I trials with delayed patient outcome. Statistics in Medicine 1999. 18:1155-1169 .
- A strategy for dose-finding and safety monitoring based on efficacy and adverse outcomes in phase I/II clinical trials. Biometrics 1998. 54:251-264 .
- Some extensions and applications of a Bayesian strategy for monitoring multiple outcomes in clinical trials. Statistics in Medicine 1998. 17:1563-1580 .
- Parametric likelihoods for multiple non-fatal competing risks and death. Statistics in Medicine 1998. 17:999-1015 .
- Variable selection in regression via repeated data splitting. Journal of Computational and Graphical Statistics 1997. 6:416-434 .
- Semiparametric regression analysis for recurrent event interval counts. Biometrics 1997. 53:1334-1353 .
- Estimating genomic category probabilities from fluorescent {\it in situ\/} hybridization counts with misclassification. Applied Statistics 1996. 45:431-446 .
- Bayesian sequential monitoring designs for single-arm clinical trials with multiple outcomes. Statistics in Medicine 1995. 14:357-379 .
- An optimal three-stage design for phase II clinical trials. Statistics in Medicine 1994. 13:1727-1736 .
- A Bayesian approach to establishing sample size and monitoring criteria for phase II clinical trials. Controlled Clinical Trials 1994. 15:463-481 .
- A Bayesian strategy for screening cancer treatments prior to phase II clinical evaluation. Statistics in Medicine 1993. 12:1197-1211 .
- Test-based variable selection via cross-validation. Journal of Computational and Graphical Statistics 1992. 1:41-61 .
- Score tests in the two-way layout of counts (Corr: 93V22 p929-930). Communications in Statistics: Theory and Methods 1992. 21:3017-3036 .
- Some covariance models for longitudinal count data with overdispersion. Biometrics 1990. 46:657-671 .
- Incorporating historical control data in planning phase II clinical trials. Statistics in Medicine 1990. 9:215-228 .
- A two-stage design for choosing among several experimental treatments and a control in clinical trials. Biometrics 1989. 45:537-547 .
- Distribution-free confidence intervals for a parameter of Wilcoxon-Mann-Whitney type for ordered categories and progressive censoring. Biometrics 1989. 45:509-521 .
- Analysis of recurrent events: Nonparametric methods for random-interval count data. Journal of the American Statistical Association 1988. 83:339-347 .
- Two-stage selection and testing designs for comparative clinical trials. Biometrika 1988. 75:303-310 .
- Mixed Poisson likelihood regression models for longitudinal interval count data (Corr: V45 p1039). Biometrics 1988. 44:197-209 .
- Optimal two-stage designs for clinical trials with binary response. Statistics in Medicine 1988. 7:571-579 .
- Assessment of stratum-covariate interactions in Cox's proportional hazards regression model. Statistics in Medicine 1986. 5:73-83 .
- A theorem on regular infinitely divisible Cox processes. Stochastic Processes and their Applications 1984. 16:205-210 .
- A joint characterization of the multinomial distribution and the Poisson process. Journal of Applied Probability 1983. 20:202-208 .
- Cluster shock models. Journal of Applied Probability 1981. 18:104-111 .
- Count distributions, orderliness and invariance of Poisson cluster processes. Journal of Applied Probability 1979. 16:261-273 .
- Huber-sense robust $M$-estimation of a scale parameter, with application to the exponential distribution. Journal of the American Statistical Association 1979. 74:147-152 .
- Random measures with aftereffects. The Annals of Probability 1978. 6:216-230 .
- On the structure of regular infinitely divisible point processes. Stochastic Processes and their Applications 1977. 6:87-94 .